OA is a condition in which the cartilage, a material that cushions the joints, breaks down. This leads to stiffness, inflammation, pain, and loss of joint movement. The exact etiology of OA is not fully understood. Obesity, overuse of the joint, weak thigh muscles, aging, and genetics are some of the common risk factors of OA; OA symptoms usually develop progressively. At first, there may be stiffness that appears to be more a niggle than a medical concern. Treatment is given depending on the affected joint, including the hand, wrist, neck, back, knee, and hip, and involves medication and exercise.
Analysts forecast the Global OA market to grow at a CAGR of 8.55 percent over the period 2014-2019.
View more details at: http://www.bigmarketresearch.com/global-osteoarthritis-2015-2019-market
Covered in this Report
This report covers the present scenario and the growth prospects of the Global OA market for the period 2015–2019. To calculate the market size, the report considers revenue generated from the sales of drugs used in the symptomatic treatment and therapeutics of OA that are available in the market. The market can be divided into three segments: Anti-inflammatories, Pain Relievers, and Drugs to Restore Articular Cartilage.
Global OA Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global OA market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
• Abbott Laboratories
• Johnson & Johnson
Other Prominent Vendors
• Abiogen Pharma
• Ampio pharmaceuticals
• BioDelivery Sciences International
• Daiichi Sankyo
• Eli Lilly
• Horizon Pharma
• Iroko Pharmaceuticals
• Nuvo Research